Business Context and Reporting Period
This Form 8-K is filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc.) on August 6, 2009. The report discloses the issuance of a press release regarding financial results for the fiscal quarter ended June 30, 2009.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1), which is not included in the provided text.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It serves solely as a notification that financial results for the quarter ended June 30, 2009, have been announced.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are expected to be found in the full text of the press release referenced as Exhibit 99.1.
Investor Verification Checklist
- Verify the correct registrant name is Oculus Innovative Sciences, Inc., as the input metadata incorrectly listed "Sonoma Pharmaceuticals, Inc."
- Review Exhibit 99.1 (the August 6, 2009 press release) to obtain actual financial figures for the quarter ended June 30, 2009.
- Confirm the specific revenue and net loss figures reported in the press release to assess performance trends.